微信公众号
证券之星APP
| 报告期 | 净资产收益率 | 同比 | 环比 | 行业排名 | 行业均值 | 行业龙头股 | 龙头股该指标值 | 查看 |
|---|---|---|---|---|---|---|---|---|
| 2024-09-30 | -12.35% | -170.83% | -39.86% | 142/160 | 4.14% | 百利天恒 | 186.1% | 行业排名> |
| 2024-06-30 | -8.83% | -379.89% | -134.22% | 142/160 | 2.6% | 百利天恒 | 186.89% | 行业排名> |
| 2024-03-31 | -3.77% | -26.94% | 63.08% | 139/160 | 2.3% | 百利天恒 | 188.56% | 行业排名> |
| 2023-12-31 | -10.21% | -613.07% | -123.9% | 129/160 | -0.96% | 小方制药 | 41.8% | 行业排名> |
| 2023-09-30 | -4.56% | -437.78% | -147.83% | 128/160 | 2.37% | 拓新药业 | 20.51% | 行业排名> |
| 2023-06-30 | -1.84% | -306.74% | 38.05% | 123/160 | 1.51% | 拓新药业 | 19.87% | 行业排名> |
| 2023-03-31 | -2.97% | -621.05% | -249.25% | 134/160 | 1.38% | 拓新药业 | 19.91% | 行业排名> |
| 2022-12-31 | 1.99% | -57.11% | 47.41% | 99/160 | 0.8% | 小方制药 | 55.57% | 行业排名> |
| 2022-09-30 | 1.35% | -74.53% | 51.69% | 102/160 | 2.89% | 福元医药 | 25.41% | 行业排名> |
| 2022-06-30 | 0.89% | -62.45% | 56.14% | 105/160 | 2.24% | 小方制药 | 34.81% | 行业排名> |
| 2022-03-31 | 0.57% | -43% | -87.72% | 106/160 | 1.61% | 退市金泰 | 10.74% | 行业排名> |
| 2021-12-31 | 4.64% | 52.13% | -12.45% | 82/160 | 0.94% | 人福医药 | 6.82% | 行业排名> |
| 2021-09-30 | 5.3% | 11.81% | 123.63% | 78/160 | 4.53% | 小方制药 | 71.99% | 行业排名> |
| 2021-06-30 | 2.37% | 29.51% | 137% | 92/160 | 2.99% | 汇宇制药 | 39.25% | 行业排名> |
| 2021-03-31 | 1% | 171.94% | -67.21% | 94/160 | 2.52% | 汇宇制药 | 28.14% | 行业排名> |
| 2020-12-31 | 3.05% | -45.24% | -35.65% | 98/160 | 3.74% | 哈三联 | 27.17% | 行业排名> |
| 2020-09-30 | 4.74% | -57.9% | 159.02% | 74/160 | 3.22% | 汇宇制药 | 55.94% | 行业排名> |
| 2020-06-30 | 1.83% | -72.06% | 231.65% | 91/160 | 4.24% | 河化股份 | 45.32% | 行业排名> |
| 2020-03-31 | -1.39% | -140.64% | -124.96% | 101/160 | 2.24% | 汇宇制药 | 31.9% | 行业排名> |
| 2019-12-31 | 5.57% | -72.43% | -50.53% | 83/160 | 2.78% | 誉衡药业 | 35.56% | 行业排名> |
| 2019-09-30 | 11.26% | -30.79% | 71.91% | 26/160 | 7.61% | 奥赛康 | 35% | 行业排名> |
| 2019-06-30 | 6.55% | -52.88% | 91.52% | 34/160 | 5.05% | 奥赛康 | 28.15% | 行业排名> |
| 2019-03-31 | 3.42% | -67.61% | -83.07% | 31/160 | 2.46% | 宏源药业 | 21.91% | 行业排名> |
| 2018-12-31 | 20.2% | 25.94% | 24.15% | 14/160 | 7.09% | 奥赛康 | 9.7% | 行业排名> |
| 2018-09-30 | 16.27% | 46.84% | 17.05% | 6/160 | 7.26% | 奥赛康 | 40.69% | 行业排名> |
| 2018-06-30 | 13.9% | 89.89% | 31.63% | 3/160 | 4.65% | 信立泰 | 25.93% | 行业排名> |
| 2018-03-31 | 10.56% | 126.61% | -34.16% | 2/160 | 2.55% | 昂利康 | 15.91% | 行业排名> |
| 2017-12-31 | 16.04% | -34.8% | 44.77% | 20/160 | 9.66% | 奥赛康 | 12.08% | 行业排名> |
| 2017-09-30 | 11.08% | -48.99% | 51.37% | 21/160 | 8.31% | 一品红 | 31.62% | 行业排名> |
| 2017-06-30 | 7.32% | -30.81% | 57.08% | 25/160 | 5.59% | 丽珠集团 | 49.43% | 行业排名> |
| 2017-03-31 | 4.66% | 5.91% | -81.06% | 8/160 | 2.1% | 河化股份 | 54.24% | 行业排名> |
| 2016-12-31 | 24.6% | 443.05% | 13.26% | 11/160 | 6.33% | 华东医药 | 7.2% | 行业排名> |
| 2016-09-30 | 21.72% | 640.3% | 105.29% | 4/160 | 5.61% | 南新制药 | 81.7% | 行业排名> |
| 2016-06-30 | 10.58% | 319.96% | 140.45% | 11/160 | 3.53% | 德展健康 | 29.5% | 行业排名> |
| 2016-03-31 | 4.4% | 578.26% | -2.87% | 15/160 | 2.65% | 贝达药业 | 16.78% | 行业排名> |
| 2015-12-31 | 4.53% | 112.36% | 212.69% | 76/160 | 11.35% | 河化股份 | 19.29% | 行业排名> |
| 2015-09-30 | -4.02% | 54.93% | 16.42% | 75/160 | 7.22% | 一品红 | 58.17% | 行业排名> |
| 2015-06-30 | -4.81% | 6.96% | -422.83% | 80/160 | 4.9% | 华东医药 | 36.97% | 行业排名> |
| 2015-03-31 | -0.92% | -4.55% | 97.49% | 71/160 | 2.41% | 华东医药 | 26.63% | 行业排名> |